OCS
Oculis Holding AG · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website oculis.com
- Employees(FY) 28
- ISIN nan
Performance
+0.08%
1W
-0.21%
1M
-4.58%
3M
+22.07%
6M
+6.63%
YTD
+1.57%
1Y
Profile
Oculis Holding AG, a clinical-stage biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. The company's lead candidate is OCS-01, a topical dexamethasone formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for keratoconjunctivitis sicca, or dry eye disease; and OCS-05, a novel neuroprotective agent for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Zug, Switzerland.
Investment Analysis Report: OCS
Overview
OCS is a company operating in the Health Technology sector, specifically in the Pharmaceuticals: Major industry. The company has a market capitalization of $459.3 million. In this report, we will conduct a detailed analysis of OCS focusing on various perspectives including Valuation, Financial Health, Ear...
Technical Analysis of OCS 2024-05-10
Overview:
In analyzing the technical indicators for OCS stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been declining, indicati...
Recent News & Updates
- 2024-01-28 17:30
Oculis to Present at Upcoming February Investor Conferences(Globenewswire)
- 2024-01-22 06:30
- 2024-01-21 17:30
- 2024-01-15 20:55
- 2023-12-20 06:30
- 2023-12-19 17:30
- 2023-12-18 06:30
- 2023-12-17 17:30
- 2023-12-07 06:30
- 2023-12-06 17:30
- 2023-11-30 06:56
- 2023-11-15 06:30
- 2023-11-14 17:30
- 2023-11-08 06:30
Oculis to Present at Upcoming November Investor Conferences(GlobeNewswire)
- 2023-11-07 17:30
Oculis to Present at Upcoming November Investor Conferences(Globenewswire)
- 2023-11-01 06:30
- 2023-10-31 18:30
- 2023-10-09 18:30
- 2023-10-04 18:30
- 2023-09-10 18:30
- 2023-08-29 18:30
Oculis to Present at Upcoming September Investor Conferences(Yahoo Finance)
- 2023-08-28 18:30
- 2023-08-07 18:30
- 2023-08-01 20:00
- 2023-07-25 20:00
- 2023-07-18 20:00
Oculis to Present at OIS Retina Innovation Summit(Yahoo Finance)
- 2023-06-25 20:00
- 2023-06-13 04:01
- 2023-06-11 20:00
- 2023-06-01 00:45